Disorder of neutral amino acid transport

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:308451
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of neutral amino acid transport (Orphanet code 308451) is a broad category encompassing rare inherited metabolic conditions in which the body's ability to transport neutral amino acids across cell membranes is impaired. The best-known condition in this group is Hartnup disease (also called Hartnup disorder), which results from defective transport of neutral amino acids (such as tryptophan, alanine, serine, threonine, valine, leucine, isoleucine, and phenylalanine) in the intestinal epithelium and renal proximal tubules. This leads to excessive urinary excretion of these amino acids (aminoaciduria) and impaired intestinal absorption. Because tryptophan is a precursor to niacin (vitamin B3), affected individuals may develop pellagra-like symptoms including a photosensitive skin rash, cerebellar ataxia, and neuropsychiatric manifestations such as emotional instability, cognitive difficulties, and psychotic episodes. Other body systems that may be affected include the gastrointestinal tract, with intermittent diarrhea reported in some patients. The clinical presentation is highly variable. Many individuals identified through newborn screening remain asymptomatic throughout life, while others develop episodic symptoms triggered by poor nutrition, illness, stress, or sun exposure. Symptoms typically first appear in childhood but can manifest at any age. The severity of clinical features often correlates with dietary niacin intake and overall nutritional status. Treatment is primarily supportive and nutritional. Oral nicotinamide (niacinamide) supplementation is the mainstay of therapy and can effectively prevent or ameliorate symptoms. A high-protein diet is recommended to compensate for impaired amino acid absorption. Sun protection is advised to prevent photosensitive skin reactions. With appropriate management, the prognosis is generally favorable, and many patients experience improvement or resolution of symptoms with age. Genetic counseling is recommended for affected families.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Disorder of neutral amino acid transport.

View clinical trials →

No actively recruiting trials found for Disorder of neutral amino acid transport at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Disorder of neutral amino acid transport community →

No specialists are currently listed for Disorder of neutral amino acid transport.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of neutral amino acid transport.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of neutral amino acid transportForum →

No community posts yet. Be the first to share your experience with Disorder of neutral amino acid transport.

Start the conversation →

Latest news about Disorder of neutral amino acid transport

No recent news articles for Disorder of neutral amino acid transport.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Disorder of neutral amino acid transport

What is Disorder of neutral amino acid transport?

Disorder of neutral amino acid transport (Orphanet code 308451) is a broad category encompassing rare inherited metabolic conditions in which the body's ability to transport neutral amino acids across cell membranes is impaired. The best-known condition in this group is Hartnup disease (also called Hartnup disorder), which results from defective transport of neutral amino acids (such as tryptophan, alanine, serine, threonine, valine, leucine, isoleucine, and phenylalanine) in the intestinal epithelium and renal proximal tubules. This leads to excessive urinary excretion of these amino acids (a

How is Disorder of neutral amino acid transport inherited?

Disorder of neutral amino acid transport follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.